Loading...
a. There shall be a commission on gender equity to study the nature and extent of inequities facing women, girls, transgender, intersex, gender non-conforming and non-binary individuals in the city; to study the impact of such inequities on the economic, civic and social well-being of women, girls, transgender, intersex, gender non-conforming and non-binary individuals; to advise on ways to analyze the function and composition of city agencies through a gender-based lens and ways to develop equitable recruitment strategies; and to make recommendations to the mayor and the council for the reduction of gender-based inequality. Such commission shall consist of 26 members appointed by the mayor; five members appointed by the speaker of the council; and the chair of the commission on human rights, who shall serve as an ex officio member. Members of the commission shall be representative of the population of the city of New York and shall have experience in advocating for issues important to women, girls, transgender, intersex, gender non-conforming and non-binary individuals. The mayor shall designate one member to serve as chair of the commission, and may also designate a member to serve as co-chair. Members shall serve at the pleasure of the appointing authority. In the event of the death or resignation of any member, a successor shall be appointed by the official who appointed such member. The mayor shall appoint an executive director for the commission.
b. The commission shall have the power and duty to:
1. Hold at least one meeting every four months, including at least one annual meeting open to the public;
2. Keep a record of its activities;
3. Determine its own rules of procedure; and
4. Perform such advisory duties and functions as may be necessary to achieve its purposes as described in subdivision a of this section.
c. The commission may request information from any city agency or office it deems necessary to enable the commission to properly carry out its functions. The commission may also request from any private organization providing services to women, girls, transgender, intersex, gender non-conforming and non-binary individuals in the city pursuant to a contract with a city agency or office, information necessary to enable the commission to properly carry out its functions.
d. No later than December 1, 2017 and annually by April 1 thereafter, the commission shall submit to the mayor and the speaker of the council and post online a report concerning its activities during the previous 12 months, the goals for the following year and recommendations pursuant to subdivision a of this section. No later than April 1, 2021, and annually thereafter, such report shall also include any recommendations the commission shall have for agencies, including, but not limited to, the department of education, for preventing and improving responses to sex- and gender-based discrimination and harassment, including, but not limited to, discrimination and harassment prohibited by section 1681 of title 20 of the United States code, or title ix of the education amendments of 1972. No later than April 1, 2021, and annually thereafter, the commission shall also post online links to data publicly reported by agencies, including, but not limited to, the department of education, relating to sex- and gender-based discrimination and harassment.
(L.L. 2016/067, 6/5/2016, eff. 9/3/2016; Am. L.L. 2020/045, 3/29/2020, eff. 3/29/2020)
a. Such agency or office that the mayor shall designate shall prepare short-term and long-term plans and recommendations to coordinate and effectively utilize private and public resources to address problems associated with illicit and non-medical drug use and to address the effects associated with past and current drug policies in this city.
b. No later than February 1, 2018, and no later than February 1 biennially thereafter, the designated agency shall prepare and submit to the mayor and the speaker of the city council a report on municipal drug strategy. The department shall consult with relevant stakeholders, including but not limited to community-based harm reduction programs, licensed substance use disorder treatment programs, healthcare providers, prevention programs, drug policy reform organizations, community-based criminal justice programs, persons directly affected by drug use, persons formerly incarcerated for drug related offenses, and experts in issues related to illicit and non-medical drug use and policies, in preparing the report. Such report shall include, but not be limited to:
1. A summary of current drug policies, programs, and services in the city, including an overview of goals to address the use of illicit and non-medical drugs such as the use of prescription drugs for non-prescription purposes;
2. A summary of interventions needed in order to reduce drug-related disease, mortality, and crime, and any inequities and disparities related to race, ethnicity, age, income, gender, geography, and immigration status;
3. An overview of programs, legislation or administrative action to promote and support health and wellness related to drug use, as well as to improve the public health and safety of the city's individuals, families, and communities by addressing the health, social and economic problems associated with illicit and non-medical drug use, past or current drug policies, and to reduce any stigma associated with drug use;
4. An overview of the city's efforts to collaborate with existing substance use, medical, and mental health services, including community-based harm reduction programs, licensed substance use disorder treatment programs, healthcare providers, formalized recovery support programs, youth prevention programs, drug policy reform programs and community-based criminal justice programs to develop and foster effective responses to illicit and non-medical drug use in the city;
5. An overview of pilot programs related to illicit and non-medical drug use;
6. An overview of any other proposals to achieve the city-wide goals and objectives related to illicit and non-medical drug use, including, if available, timelines for implementation; and
7. Data on the projected number of opioid antagonists needed by all relevant city agencies, the actual number of opioid antagonists distributed to all relevant city agencies and the number of opioid antagonists distributed to registered opioid overdose prevention programs citywide.
c. There shall be a municipal drug strategy advisory council whose members shall include, but not be limited to, the head of the designated agency, or their representative, who shall be chair, a representative from the department of health and mental hygiene, the department of education, the health and hospitals corporation, the police department, the administration for children's services, the human resources administration, the department of corrections, the department of probation, and the department of homeless services, the speaker of the city council and up to three members appointed by the speaker, and representatives of any other agencies that the head of the designated agency may designate, as well as at least eight representatives, including but not limited to at least one from each of the following: continuum of care providers, those directly affected by drug use, those in recovery from drug use, people formerly incarcerated for drug related offenses, and experts in issues related to illicit and non-medical drug use and policies. The head of the designated agency or their representative may establish subcommittees comprised of governmental or nongovernmental representatives as deemed necessary to accomplish the work of the municipal drug strategy advisory council. The municipal drug strategy advisory council shall:
1. Make recommendations to the head of the designated agency regarding the development of the municipal drug strategy report required pursuant to this section;
2. Produce an advisory addendum, as deemed necessary by the municipal drug strategy advisory council, to the New York municipal city drug policy strategy report, as prepared by the head of the designated agency, pursuant to subdivision c of this section;
3. Advise on relevant federal, state, and local legislation, programs, and other governmental activities;
4. Make recommendations to the head of the designated agency regarding the implementation of city-wide goals and objectives related to the risks associated with illicit and non-medical drug use; and
5. Hold at least four meetings each fiscal year, at least one of which shall be open to the general public for input and comments.
(L.L. 2017/048, 3/21/2017, eff. 3/21/2017; Am. L.L. 2018/129, 6/26/2018, eff. 6/26/2018)
Editor's note: For related unconsolidated provisions, see Administrative Code Appendix A at L.L. 2017/048 and L.L. 2018/129.
Loading...